1
|
Ouzzif Z, Eddair Y, Laassara W, El Maaroufi H, Mahtat EM. Non-Secretory Multiple Myeloma: A New Observation and Review of the Literature. Cureus 2024; 16:e54479. [PMID: 38510859 PMCID: PMC10954289 DOI: 10.7759/cureus.54479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/16/2024] [Indexed: 03/22/2024] Open
Abstract
Non-secreting multiple myeloma is a rare variant of multiple myeloma that affects a relatively young population. It is characterized by the non-secretory nature of malignant plasma cells. The following case report describes the history of a 54-year-old patient with non-secretory myeloma revealed by mechanical and inflammatory low back pain. The bone and neurological involvement, the presence of diffuse osteolytic lesions and the increase in the serum kappa free light chains (FLC) level prompted a myelogram. This finds medullary invasion by dystrophic plasma cells. The absence of detection of complete or incomplete monoclonal immunoglobulin in the blood and urine, as well as the revelation of cytogenetic abnormalities of plasma cells, allows the diagnosis of non-secreting multiple myeloma to be made. This clinical case aims to describe the unusual presentation of this rare form of multiple myeloma.
Collapse
Affiliation(s)
- Zohra Ouzzif
- Biochemistry, Metabolic and Molecular Unit, Faculty of Medicine and Pharmacy, Mohammed V Military Training Hospital, Mohammed V University, Rabat, MAR
| | - Yassine Eddair
- Hematology and Immunohematology Laboratory, Faculty of Medicine and Pharmacy, Mohammed V Military Training Hospital, Mohammed V University, Rabat, MAR
| | - Wissal Laassara
- Hematology and Immunohematology Laboratory, Faculty of Medicine and Pharmacy, Mohammed V Military Training Hospital, Mohammed V University, Rabat, MAR
| | - Hicham El Maaroufi
- Department of Clinical Hematology, Faculty of Medicine and Pharmacy, Mohammed V Military Training Hospital, Mohammed V University, Rabat, MAR
| | - El Mehdi Mahtat
- Department of Clinical Hematology, Faculty of Medicine and Pharmacy, Mohammed V Military Training Hospital, Mohammed V University, Rabat, MAR
| |
Collapse
|
2
|
Hammani A, Doghmi O, Allaoui M, Ababou M, Mahtat EM, El Maaroufi H, Doghmi K. A Rare Coexistence of Smoldering Multiple Myeloma and JAK2-Positive Myeloproliferative Neoplasm: A Case of Dual Synchronous Hematological Malignancy. Cureus 2024; 16:e52622. [PMID: 38374866 PMCID: PMC10876019 DOI: 10.7759/cureus.52622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/20/2024] [Indexed: 02/21/2024] Open
Abstract
This article explores the rare case of an 82-year-old man diagnosed concurrently with essential thrombocythemia and smoldering multiple myeloma (SMM). The limited existing literature on individuals harboring both myeloproliferative neoplasm (MPN) and monoclonal gammopathy (MG) is of significant interest due to the distinct origins of these malignancies. The etiology of MG in MPN patients remains elusive, leading to speculation about a potential relationship or interplay between the two conditions. This unique case prompts a deeper exploration of the mechanisms underlying the coexistence of JAK2-positive MPN and SMM. It underscores the importance of tailored therapeutic strategies that carefully consider the inherent risks and potential adverse outcomes associated with these specific malignancies, thereby warranting further clinical research.
Collapse
Affiliation(s)
- Adnane Hammani
- Hematology, Mohammed V Military Training Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR
| | - Othman Doghmi
- Hematology, Ibn Sina University Hospital Center, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR
| | - Mohammed Allaoui
- Pathology, Mohammed V Military Training Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR
| | - Mounir Ababou
- Hematology, Mohammed V Military Training Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR
| | - El Mehdi Mahtat
- Hematology, Mohammed V Military Training Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR
| | - Hicham El Maaroufi
- Hematology, Mohammed V Military Training Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR
| | - Kamal Doghmi
- Hematology, Mohammed V Military Training Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR
| |
Collapse
|
3
|
Oumayma H, Mahtat EM, Moussa Bouh H, Elmaaroufi H, Doghmi K. Fatal Cryptococcal Meningitis in a Patient With Chronic Lymphocytic Leukemia Treated With Ibrutinib. Cureus 2023; 15:e37891. [PMID: 37213990 PMCID: PMC10199734 DOI: 10.7759/cureus.37891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/20/2023] [Indexed: 05/23/2023] Open
Abstract
According to the latest World Health Organization classification published in 2022, chronic lymphocytic leukemia (CLL) is classified as a low-grade proliferation of clonal B-cells. The Bruton tyrosine kinase (BTK) pathway plays a crucial role in B-cell receptor signaling. Ibrutinib, the first irreversible BTK inhibitor, has been shown to improve the survival of CLL patients with lower toxicity than traditional chemotherapy. Cryptococcosis is an invasive fungal infection that primarily affects individuals with compromised immune systems. We present a case of a 69-year-old male with relapsed CLL who received treatment with ibrutinib and subsequently developed meningeal cryptococcosis, presenting with seizures and fever. A physical exam showed bilateral hypoacusis, but no focal deficits. Cerebral imaging was normal and laboratory results showed a low gamma globulin level and leucopenia with lymphopenia but without neutropenia. The cerebrospinal fluid profile was not inflammatory, opening pressure was normal, the classic India ink test was positive, and fungal cultures grew Cryptococcus neoformans. To complete investigations, HIV testing was negative, and sinus and chest tomography scans showed no anomalies. Treatment consisted of discontinuing ibrutinib and administering anti-fungal therapy with liposomal amphotericin (4 mg/kg/day) in combination with flucytosine (25 mg/kg/day). However, the patient's neurological status declined, and he passed away. This case highlights the potential risk of developing opportunistic infections such as cryptococcal meningitis in CLL patients treated with ibrutinib. It is crucial to consider the patient's immune status when administering ibrutinib and to closely monitor for signs of infection.
Collapse
Affiliation(s)
- Hari Oumayma
- Hematology Department, Military Hospital, Rabat, MAR
| | | | | | | | - Kamal Doghmi
- Hematology Department, Military Hospital, Rabat, MAR
| |
Collapse
|
4
|
Jennane S, Mahtat EM, Ababou M, El Maaroufi H, Doghmi K. Posterior Reversible Encephalopathy Syndrome Secondary to R-CHOP Chemotherapy Regimen. Cureus 2022; 14:e24988. [PMID: 35719806 PMCID: PMC9191265 DOI: 10.7759/cureus.24988] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/11/2022] [Indexed: 11/05/2022] Open
|
5
|
Jennane S, Ababou M, El Haddad M, Ait Sahel O, Mahtat EM, El Maaroufi H, Doudouh A, Doghmi K. Bleomycin-Induced Lung Toxicity in Hodgkin's Lymphoma: Risk Factors in the Positron Emission Tomography Era. Cureus 2022; 14:e23993. [PMID: 35419251 PMCID: PMC8994685 DOI: 10.7759/cureus.23993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/09/2022] [Indexed: 12/01/2022] Open
Abstract
Introduction Bleomycin is a major antimitotic agent in the first-line treatment for Hodgkin's lymphoma. The main limitation of its use is its pulmonary toxicity. The objectives of this study are to find out the risk factors for the occurrence of bleomycin-induced lung toxicity in patients with Hodgkin's lymphoma and, on the other hand, to determine if positron emission tomography scan is a reliable means of early detection of this toxicity. Methods This is a retrospective study conducted in the clinical Hematology Department of Mohammed V Military Instruction Hospital, Rabat, Morocco. All patients with Hodgkin's lymphoma and treated with a bleomycin-based chemotherapy were included. The impact of different clinical and biological factors on the risk of bleomycin-induced lung toxicity occurrence was assessed using univariate and multivariate logistic regression. The benefit of positron emission tomography, usually performed as part of the re-assessment of Hodgkin’s lymphoma after two and four cycles, has been evaluated in the detection of bleomycin-induced lung toxicity. Results Among 124 patients included in the study, 18 (14.5%) patients experienced bleomycin-induced lung toxicity. On multivariate analysis, smoking (p = 0.038) and the use of the ABVD regimen (doxorubicin, bleomycin, vinblastine, and dacarbazine) compared to the escalated BEACOPPe regimen (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) (p = 0.018) were statistically significant risk factors. After two and four courses of therapy, the positron emission tomography was able to predict the occurrence of bleomycin-induced lung toxicity before the appearance of clinical symptoms only in 36.4 % and 12.5% of patients, respectively. Conclusion Studies to identify risk factors for the development of bleomycin-induced lung toxicity are crucial to reduce toxicity in the treatment of Hodgkin's lymphoma. However, two- and four-cycle positron emission tomography scans cannot be considered as a reliable means of early detection of this toxicity.
Collapse
|
6
|
Laktib N, Mahtat EM, Lahlafi Z, Mouine N, Asfalou I, Aghoutane N, Chaib A, Lakhal Z, Doghmi K, Benyass A. Essential thrombocythemia and aortic dissection,causal or incidental association? J Med Vasc 2022; 47:39-42. [PMID: 35393092 DOI: 10.1016/j.jdmv.2022.01.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/26/2021] [Accepted: 01/12/2022] [Indexed: 06/14/2023]
Abstract
Only few cases of vascular dissection and essential thrombocythemia association have been reported. To the best of our knowledge, we reported the second case of aortic dissection and essential thrombocythemia association in a 60-year-old man with positive JAK2V617F mutation who had no history of hypertension or connective tissue disorders. Through this case, we discussed the eventual existence of a causal relationship between the two conditions. We also suggested the use of hydroxyurea as a prevention treatment of thrombosis in myeloproliferative neoplasms.
Collapse
Affiliation(s)
- Nabil Laktib
- Department of Cardiology Intensive Care Unit, Cardiology Center of Mohammed V Military Training Hospital, Rabat, Morocco.
| | - El Mehdi Mahtat
- Department of Hematology, Mohammed V Military Training Hospital, Rabat, Morocco
| | - Zakaria Lahlafi
- Catheterization laboratory, Cardiology Center of Mohammed V Military Training Hospital, Rabat, Morocco
| | - Najat Mouine
- Department of Clinical Cardiology, Cardiology Center of Mohammed V Military Training Hospital, Rabat, Morocco
| | - Iliyasse Asfalou
- Department of non-Invasive Cardiac Explorations, Cardiology Center of Mohammed V Military Training Hospital, Rabat, Morocco
| | - Nabil Aghoutane
- Department of Vascular Surgery, Mohammed V Military Training Hospital, Rabat, Morocco
| | - Ali Chaib
- Department of Rhythmology, Cardiology Center of Mohammed V Military Training Hospital, Rabat, Morocco
| | - Zouhair Lakhal
- Department of Cardiology Intensive Care Unit, Cardiology Center of Mohammed V Military Training Hospital, Rabat, Morocco
| | - Kamal Doghmi
- Department of Hematology, Mohammed V Military Training Hospital, Rabat, Morocco
| | - Aatif Benyass
- Cardiology Center of Mohammed V Military Training Hospital, Rabat, Morocco
| |
Collapse
|
7
|
Jennane S, El Maaroufi H, Mahtat EM, Mikdame M, Doghmi K. Bing-Neel syndrome revealing Waldenström's macroglobulinemia: a case report. Tunis Med 2020; 98:750-753. [PMID: 33479948] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
INTRODUCTION Bing-Neel syndrome is a lympho-plasmocytic infiltration of the central nervous system. The Bing-Neel syndrome is a rare entity, which often occurs during the evolution of a Waldenström's macroglobulinemia but can in some cases be the revealing mode of it. OBSERVATION We report the case of a 56-year-old patient with tumoral form of Bing-Neel syndrome revealing Waldentrom's macroglobulinemia. CONCLUSION This observation describes a rare entity whose diagnosis and therapeutic management is complex.
Collapse
|
8
|
Mahtat EM, Hasnaoui N, Zahid H. Bone pain, splenomegaly and microcytic anemia in a young woman. Eur J Intern Med 2020; 78:129-130. [PMID: 32622515 DOI: 10.1016/j.ejim.2020.06.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/27/2020] [Accepted: 06/25/2020] [Indexed: 11/18/2022]
Affiliation(s)
- El Mehdi Mahtat
- Clinical Hematology Department, Mohammed V Military Teaching Hospital, Rabat, Morocco; Université Mohamed V, Rabat, Morocco.
| | - Naoual Hasnaoui
- Clinical Hematology Department, Mohammed V Military Teaching Hospital, Rabat, Morocco
| | - Hafid Zahid
- Université Mohamed V, Rabat, Morocco; Hematology Laboratory, Mohammed V Military Teaching Hospital, Rabat, Morocco
| |
Collapse
|
9
|
Benlachgar N, Doghmi K, Masrar A, Mahtat EM, Harmouche H, Tazi Mezalek Z. Immature platelets: a review of the available evidence. Thromb Res 2020; 195:43-50. [PMID: 32652352 DOI: 10.1016/j.thromres.2020.06.048] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2019] [Revised: 05/12/2020] [Accepted: 06/30/2020] [Indexed: 12/28/2022]
Abstract
Immature platelets or reticulated platelets are newly released thrombocytes. They can be identified by their large size and high RNA cytoplasm concentration. Immature platelet fraction (IPF) represents the percentage of immature circulative platelets to the total number of platelets. The development of analytical standardization of this hematological parameter by new automated devices allowed a better exploration of its contribution in a context of thrombocytopenia. In fact, several studies had confirmed its clinical utility to differentiate immune thrombocytopenia from other causes of thrombocytopenia. IPF can also predict platelets recovery after chemotherapy and successful engraftment. In addition, immature platelets have shown utility in other diseases such as coronary artery diseases, bacterial infections and liver diseases. Despite all these advantages, immature platelet fraction can be increased in some cases of thrombocytopenia characterized by platelets hypoproduction. The aim of this review is to present the immature platelet fraction contribution in clinical practice.
Collapse
Affiliation(s)
- Naoufal Benlachgar
- Department of Clinical Haematology, Military Hospital of Instruction Mohamed V, Rabat, Morocco.
| | - Kamal Doghmi
- Department of Clinical Haematology, Military Hospital of Instruction Mohamed V, Rabat, Morocco
| | - Azlarab Masrar
- Central laboratory of hematology, Ibn Sina Hospital, University Mohamed V of Medicine, Rue Lamfadel Cherkaoui, BP 6527 Rabat, Morocco
| | - El Mehdi Mahtat
- Department of Clinical Haematology, Military Hospital of Instruction Mohamed V, Rabat, Morocco
| | - Hicham Harmouche
- Internal Medicine Department, Ibn Sina Hospital, University Mohamed V of Medicine, Rue Lamfadel Cherkaoui, BP 6527 Rabat, Morocco
| | - Zoubida Tazi Mezalek
- Internal Medicine Department, Ibn Sina Hospital, University Mohamed V of Medicine, Rue Lamfadel Cherkaoui, BP 6527 Rabat, Morocco
| |
Collapse
|
10
|
Jennane S, Hasnaoui N, Mahtat EM, Merimi F, Bougar S, El Maaroufi H, Belmekki A, Zafad S, Essakalli M, Mikdame M, Doghmi K. Non-cryopreserved peripheral blood stem cells autologous transplantation in multiple myeloma: Bicentric study. Transfus Clin Biol 2020; 27:152-156. [PMID: 32334934 DOI: 10.1016/j.tracli.2020.03.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2020] [Revised: 03/28/2020] [Accepted: 03/30/2020] [Indexed: 10/24/2022]
Abstract
OBJECTIVES The objective of this study is to evaluate the toxicity of autologous transplantation of non-frozen peripheral blood stem cells in Moroccan patients with multiple myeloma. MATERIAL AND METHODS This was a bicentric retrospective study conducted in the Clinical Haematology Department of Mohammed V Military Teaching Hospital and at the Al Madina Clinic in Casablanca. The study period was from January 2015 to June 2019. All patients with multiple myeloma who had undergone an autologous peripheral stem cell transplant without freezing were included. Mobilisation was performed with lenograstim alone and the collected stem cells were stored for 24-48hours in a blood bank refrigerator at a temperature of 4°C. After standard conditioning with high-dose melphalan, the peripheral blood stem cells were reinjected 24 h following conditioning. RESULTS Over the study period, 55 patients received an autologous transplant using non-frozen peripheral blood stem cells. The median richness of the CD34 cells collected was 4.5×106 CD34/kg (range: 2-12.2). The time required for neutrophil recovery was 12 days (range: 7-19). The time required for platelet recovery was 14 days (range: 9-32). The mortality rate within 100 days post-transplant was 3.6%. We did not observe any cases of graft failure. CONCLUSION Our study finds good feasibility and low toxicity of autologous peripheral stem cell transplantation without freezing in patients with multiple myeloma.
Collapse
Affiliation(s)
- S Jennane
- Service d'Hématologie Clinique, Hôpital Militaire d'Instruction Mohammed V de Rabat, Faculté de Médecine et de Pharmacie de Rabat, Université Mohammed V de Rabat, Rabat, Maroc.
| | - N Hasnaoui
- Service d'Hématologie Clinique, Hôpital Militaire d'Instruction Mohammed V de Rabat, Faculté de Médecine et de Pharmacie de Rabat, Université Mohammed V de Rabat, Rabat, Maroc
| | - E M Mahtat
- Service d'Hématologie Clinique, Hôpital Militaire d'Instruction Mohammed V de Rabat, Faculté de Médecine et de Pharmacie de Rabat, Université Mohammed V de Rabat, Rabat, Maroc
| | - F Merimi
- Clinique privée Al Madina, Casablanca, Maroc
| | - S Bougar
- Service de Transfusion et d'Immunologie, Banque de Tissus et Cellules, Centre Hospitalier Universitaire Ibn Sina, Université Mohammed V de Rabat, Rabat, Maroc
| | - H El Maaroufi
- Service d'Hématologie Clinique, Hôpital Militaire d'Instruction Mohammed V de Rabat, Faculté de Médecine et de Pharmacie de Rabat, Université Mohammed V de Rabat, Rabat, Maroc
| | - A Belmekki
- Centre de Transfusion Sanguine Hôpital Militaire d'Instruction Mohammed V de Rabat, Faculté de Médecine et de Pharmacie de Rabat, Université Mohammed V de Rabat, Rabat, Maroc
| | - S Zafad
- Clinique privée Al Madina, Casablanca, Maroc
| | - M Essakalli
- Service de Transfusion et d'Immunologie, Banque de Tissus et Cellules, Centre Hospitalier Universitaire Ibn Sina, Université Mohammed V de Rabat, Rabat, Maroc
| | - M Mikdame
- Faculté de Médecine et de Pharmacie de Rabat, Université Mohammed V de Rabat, Rabat, Maroc
| | - K Doghmi
- Service d'Hématologie Clinique, Hôpital Militaire d'Instruction Mohammed V de Rabat, Faculté de Médecine et de Pharmacie de Rabat, Université Mohammed V de Rabat, Rabat, Maroc
| |
Collapse
|
11
|
Ben El Makki A, Mahtat EM, Kheyi J, Bouzelmat H, Chaib A. A rare case of perimyocarditis induced by all-trans retinoic acid administration during induction treatment of acute promyelocytic leukemia. Med Pharm Rep 2019; 92:418-420. [PMID: 31750445 PMCID: PMC6853053 DOI: 10.15386/mpr-1229] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2018] [Revised: 04/01/2019] [Accepted: 04/17/2019] [Indexed: 11/23/2022] Open
Abstract
Treatment by All-Trans Retinoic Acid (ATRA) combined with an Anthracycline Chemotherapy has been shown to improve disease-free survival in patients with Acute Promyelocytic Leukemia (APL). Although ATRA is generally well tolerated, occurrence of Retinoic Acid Syndrome (RAS) during the induction chemotherapy in some patients is recognized as a distinct complication and a potential life-threatening side effect. Isolated myocarditis as a result of RAS related to ATRA administration is uncommon and has been rarely reported in the literature. We report a very rare case of ATRA-induced perimyocarditis accompanied by hemodynamic compromise. There was complete resolution of the signs and symptoms of peri-myocarditis when ATRA was temporary suspended. Finally, ATRA was safely resumed.
Collapse
Affiliation(s)
- Abdelilah Ben El Makki
- Department of Cardiology, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy Mohammed V, University Rabat, Morocco
| | - El Mehdi Mahtat
- Department of Hematology, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy Mohammed V, University Rabat, Morocco
| | - Jamal Kheyi
- Department of Cardiology, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy Mohammed V, University Rabat, Morocco
| | - Hicham Bouzelmat
- Department of Cardiology, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy Mohammed V, University Rabat, Morocco
| | - Ali Chaib
- Department of Cardiology, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy Mohammed V, University Rabat, Morocco
| |
Collapse
|
12
|
Eddou H, Zinebi A, Khalloufi A, Mahtat EM, El Khadir SE, Moudden MK, Doghmi K, Mikdame M, El Baaj M. [Thrombo-haemorrhagic disease-related hypoprothrombinemia-lupus anticoagulant syndrome revealing a light chains multiple myeloma]. J Med Vasc 2018; 43:325-328. [PMID: 30217348 DOI: 10.1016/j.jdmv.2018.07.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/06/2018] [Accepted: 07/08/2018] [Indexed: 06/08/2023]
Abstract
Thrombosis and hemorrhage are two opposing manifestations of multiple myeloma. These hemostatic disorders are present in less than 12% of patients at diagnosis and involve various pathophysiological mechanisms. We report the case of a 39-year-old patient with multiple myeloma revealed by the association of a hemorrhagic syndrome and deep vein thrombosis related to a hypoprothrombinemia-anticoagulant lupus syndrome.
Collapse
Affiliation(s)
- H Eddou
- Service de médecine A, hôpital Militaire Moulay Ismail Meknès, Maroc; Faculté de médecine et de pharmacie de Fès, Maroc.
| | - A Zinebi
- Service de médecine A, hôpital Militaire Moulay Ismail Meknès, Maroc
| | - A Khalloufi
- Service d'hématologie biologique, hôpital Militaire Moulay Ismail Meknès, Maroc
| | - E M Mahtat
- Service d'hématologie clinique, hôpital Militaire d'instruction Mohammed V Rabat, Maroc
| | - S E El Khadir
- Service de médecine A, hôpital Militaire Moulay Ismail Meknès, Maroc
| | - M K Moudden
- Service de médecine A, hôpital Militaire Moulay Ismail Meknès, Maroc
| | - K Doghmi
- Service d'hématologie clinique, hôpital Militaire d'instruction Mohammed V Rabat, Maroc
| | - M Mikdame
- Service d'hématologie clinique, hôpital Militaire d'instruction Mohammed V Rabat, Maroc
| | - M El Baaj
- Service de médecine A, hôpital Militaire Moulay Ismail Meknès, Maroc
| |
Collapse
|
13
|
Jennane S, Haidouri S, Zine Filali K, Ahchouch S, Mahtat EM, Doghmi K, Mikdame M. [Fatal bleomycin induced pneumomediastinum and bilateral pneumothorax]. Rev Pneumol Clin 2017; 73:153-156. [PMID: 28365047 DOI: 10.1016/j.pneumo.2017.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/03/2016] [Accepted: 02/03/2017] [Indexed: 06/07/2023]
Affiliation(s)
- S Jennane
- Service d'hématologie clinique, hôpital militaire d'instruction Mohammed V, Hay Riad BP 10100, Rabat, Maroc.
| | - S Haidouri
- Service d'hématologie clinique, hôpital militaire d'instruction Mohammed V, Hay Riad BP 10100, Rabat, Maroc
| | - K Zine Filali
- Service d'hématologie clinique, hôpital militaire d'instruction Mohammed V, Hay Riad BP 10100, Rabat, Maroc
| | - S Ahchouch
- Service d'hématologie clinique, hôpital militaire d'instruction Mohammed V, Hay Riad BP 10100, Rabat, Maroc
| | - E M Mahtat
- Service d'hématologie clinique, hôpital militaire d'instruction Mohammed V, Hay Riad BP 10100, Rabat, Maroc
| | - K Doghmi
- Service d'hématologie clinique, hôpital militaire d'instruction Mohammed V, Hay Riad BP 10100, Rabat, Maroc
| | - M Mikdame
- Service d'hématologie clinique, hôpital militaire d'instruction Mohammed V, Hay Riad BP 10100, Rabat, Maroc
| |
Collapse
|
14
|
Mahtat EM, Zine M, Allaoui M, Kerbout M, Messaoudi N, Doghmi K, Mikdame M. Hemophagocytic lymphohistiocytosis complicating a T-cell rich B-cell lymphoma. BMC Hematol 2016; 16:28. [PMID: 27904750 PMCID: PMC5122011 DOI: 10.1186/s12878-016-0065-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/29/2016] [Accepted: 10/07/2016] [Indexed: 01/16/2023]
Abstract
Background Hemophagocytic lymphohistiocytosis in adults is often secundary to an infection or a neoplasm. In this last case, T cell lymphomas are the most frequent causes. Hemophagocytic lymphohistiocytosis secundary to a B cell lymphoma has been rarely reported. Case presentation We describe a case of a hemophagocytic lymphohistiocytosis complicating a T-cell rich B-cell lymphoma treated with conventionnal chemotherapy leading to a complete remission. Conclusion Prompt etiologic diagnosis and treatment of hemophagocytic lymphohistiocytosis leads to satisfactory outcome.
Collapse
Affiliation(s)
- El Mehdi Mahtat
- Service d'Hématologie Clinique, Hôpital Militaire d'Instruction Mohamed V, Rabat, Morocco
| | - Maryem Zine
- Service d'Hématologie Clinique, Hôpital Militaire d'Instruction Mohamed V, Rabat, Morocco
| | - Mohamed Allaoui
- Laboratoire d'Anatomie Pathologique, Hôpital Militaire d'Instruction Mohamed V, Rabat, Morocco
| | - Malika Kerbout
- Service d'Hématologie Clinique, Hôpital Militaire d'Instruction Mohamed V, Rabat, Morocco
| | - Nezha Messaoudi
- Service d'Hématologie Clinique, Hôpital Militaire d'Instruction Mohamed V, Rabat, Morocco
| | - Kamal Doghmi
- Service d'Hématologie Clinique, Hôpital Militaire d'Instruction Mohamed V, Rabat, Morocco
| | - Mohamed Mikdame
- Service d'Hématologie Clinique, Hôpital Militaire d'Instruction Mohamed V, Rabat, Morocco
| |
Collapse
|
15
|
Allaoui M, Benchafai I, Mahtat EM, Regragui S, Boudhas A, Azzakhmam M, Boukhechba M, Al Bouzidi A, Oukabli M. Primary Burkitt lymphoma of the thyroid gland: case report of an exceptional type of thyroid neoplasm and review of the literature. BMC Clin Pathol 2016; 16:6. [PMID: 27175103 PMCID: PMC4864901 DOI: 10.1186/s12907-016-0028-6] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2016] [Accepted: 05/05/2016] [Indexed: 11/10/2022] Open
Abstract
Background Primary thyroid lymphoma is an uncommon pathological entity that accounts for only 1 to 5 % of all thyroid malignancies. Primary Burkitt lymphoma of the thyroid gland is very rare. This article presents the first Moroccan case of a primary BL of the thyroid to be reported in the literature to date. Case presentation We describe here a case of a 70-year-old male who developed a rapidly enlarging thyroid gland with progressive symptoms of compression. Core biopsy confirmed the diagnosis of Burkitt lymphoma. The patient died of septic shock, 2 weeks after the first cycle of appropriate therapeutic chemotherapy. Conclusions This presentation emphasizes the importance of considering lymphoma when dealing with a thyroid mass, as its management is different from that of other thyroid pathologies, and affords an opportunity to review a very rare type of primary thyroid lymphoma.
Collapse
Affiliation(s)
- Mohamed Allaoui
- Department of Pathology, Military General Hospital Mohammed V, Mohammed V Souissi University - Faculty of Medicine and Pharmacy of Rabat, Hay Riad, Rabat, 10000 Morocco
| | - Ilias Benchafai
- Department of Clinical Haematology, Military General Hospital Mohammed V, Mohammed V Souissi University - Faculty of Medicine and Pharmacy of Rabat, Hay Riad, Rabat, 10000 Morocco
| | - El Mehdi Mahtat
- Department of Otorhinolaryngology, Military General Hospital Mohammed V, Mohammed V Souissi University - Faculty of Medicine and Pharmacy of Rabat, Hay Riad, Rabat, 10000 Morocco
| | - Safae Regragui
- Department of Otorhinolaryngology, Military General Hospital Mohammed V, Mohammed V Souissi University - Faculty of Medicine and Pharmacy of Rabat, Hay Riad, Rabat, 10000 Morocco
| | - Adil Boudhas
- Department of Pathology, Military General Hospital Mohammed V, Mohammed V Souissi University - Faculty of Medicine and Pharmacy of Rabat, Hay Riad, Rabat, 10000 Morocco
| | - Mustapha Azzakhmam
- Department of Pathology, Military General Hospital Mohammed V, Mohammed V Souissi University - Faculty of Medicine and Pharmacy of Rabat, Hay Riad, Rabat, 10000 Morocco
| | - Mohammed Boukhechba
- Department of Pathology, Military General Hospital Mohammed V, Mohammed V Souissi University - Faculty of Medicine and Pharmacy of Rabat, Hay Riad, Rabat, 10000 Morocco
| | - Abderrahmane Al Bouzidi
- Department of Pathology, Military General Hospital Mohammed V, Mohammed V Souissi University - Faculty of Medicine and Pharmacy of Rabat, Hay Riad, Rabat, 10000 Morocco
| | - Mohamed Oukabli
- Department of Pathology, Military General Hospital Mohammed V, Mohammed V Souissi University - Faculty of Medicine and Pharmacy of Rabat, Hay Riad, Rabat, 10000 Morocco
| |
Collapse
|
16
|
Jennane S, Mahtat EM, Konopacki J, Malfuson JV, Doghmi K, Mikdame M, De Revel T. Cyclosporine-related posterior reversible encephalopathy syndrome after cord blood stem cell transplantation. Hematol Oncol Stem Cell Ther 2013; 6:71. [PMID: 23707936 DOI: 10.1016/j.hemonc.2013.05.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/18/2013] [Indexed: 11/25/2022] Open
Affiliation(s)
- Selim Jennane
- Service d'hématologie clinique, hôpital militaire d'instruction Mohammed V, Rabat, Morocco.
| | | | | | | | | | | | | |
Collapse
|